Hemas posts record FY26 earnings

Hemas Holdings PLC reported record earnings for FY26, with full-year profit rising 10.7% year-on-year to Rs 8.92 billion.

The group also posted record fourth-quarter earnings of Rs 3.03 billion, up 17.6% from a year earlier. Revenue for the year increased 8.0% to Rs 127.4 billion, with all three main business segments recording growth.

Gross profit margin improved by 110 basis points, although EBITDA and EBIT margins narrowed as Hemas increased spending on staff, digital systems, and healthcare expansion.

Consumer Brands revenue grew 2.2%, while earnings rose 6.5%, supported by volume growth. Healthcare revenue increased 11.5%, with earnings up 14.2%, while the Mobility sector recorded 17.8% revenue growth and 6.1% earnings growth.

Morison, the group’s pharmaceutical manufacturing arm, recorded 18.6% volume growth, while hospital revenue rose 24% following higher activity across services and the expansion of the Wattala facility.

Hemas said it has earmarked more than $ 100 million for investments over the next four years, with a focus on international expansion and related business growth. International revenue currently stands at 3%, while a planned FY27 acquisition is expected to raise it to 10%.

source: The morning